Product Details
Braftovi 75 mg Capsules**
Encorafenib75 mg
Capsule
ROA
Oral
Applicant Name
Pfizer Specialties Ltd
NRN
A4-100331
Status
Active
Composition
Each hard capsule contains: Encorafenib 75 mg. Excipients: Capsule content - Copovidone (E1208) Poloxamer 188 Cellulose microcrystalline (E460i) Succinic acid (E363) Crospovidone (E1202) Silica colloidal anhydrous (E551) Magnesium stearate (E470b) Capsule shell - Gelatin (E441) Titanium dioxide (E171) Iron oxide red (E172) Iron oxide yellow (E172) Iron oxide black (E172)
ATC Code
L01EC03
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
42's (in polyamide/aluminium/PVC/aluminium/ PET/paper perforated unit dose blisters)
Product Description
Hard capsule (capsule). Flesh coloured opaque cap and white opaque body, printed with a stylised “A” on the cap and “LGX 75mg” on the body. The length of the capsule is approximately 23 mm
Manufacturer Name
Catalent Pharma Solutions LLC
Manufacturer Country
UNITED STATES OF AMERICA
Approval Date
2023-01-26
Expiry Date
2028-01-25